How can physicians and their patients with ALS decide to use the newly-available treatments to slow disease progression?

Carmel Armon

doi:10.1080/14660829952415945

How can physicians and their patients with ALS decide to use the newly-available treatments to slow disease progression?

Neurology

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	3-14
Number of pages	12
Journal	Amyotrophic Lateral Sclerosis
Volume	1
Issue number	1
DOIs	https://doi.org/10.1080/14660829952415945
State	Published - 2000

ASJC Scopus Subject Areas

Neurology
Clinical Neurology

Keywords

amyotrophic lateral sclerosis
measures of disease progression
outcome measures
quality of life
treatment

Access to Document

10.1080/14660829952415945

OpenUrl availability

Full text

Cite this

@article{677984a11ede4cfabce4b11a320f0439,

title = "How can physicians and their patients with ALS decide to use the newly-available treatments to slow disease progression?",

keywords = "amyotrophic lateral sclerosis, measures of disease progression, outcome measures, quality of life, treatment",

author = "Carmel Armon",

year = "2000",

doi = "10.1080/14660829952415945",

language = "English",

volume = "1",

pages = "3--14",

journal = "Amyotrophic Lateral Sclerosis",